Zoe Secures $15M for U.S. Expansion in Microbiome Nutrition.
Zoe, a London-based microbiome-focused nutrition company, has raised $15 million in a Series B extension to expand in the U.S., bringing its total funding to $118 million. Zoe provides at-home testing kits for blood and gut microbiome health, offering personalized food scores and dietary advice to users. The company recently published a randomized controlled trial in Nature Medicine, demonstrating that its program significantly improves biological markers and overall well-being. CEO Jonathan Wolf emphasized that Zoe focuses on nutrition rather than weight loss, and highlighted the company’s growth to over 100,000 paid subscribers. The new funding will support increased marketing efforts and further expansion in the U.S., where Zoe’s products are currently available everywhere except New York..
